Fluticasone Propionate/Salmeterol Combination Product
Sponsors
GlaxoSmithKline
Conditions
Pulmonary Disease, Chronic Obstructive
Phase 4
Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations
CompletedNCT00115492
Start: 2004-12-31End: 2007-06-30Updated: 2017-01-20
ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.
CompletedNCT00144911
Start: 2004-10-31End: 2006-12-31Updated: 2016-10-28
ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.
TerminatedNCT00346749
Start: 2006-12-31End: 2007-07-31Target: 180Updated: 2016-10-28
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
CompletedNCT00984659
Start: 2009-10-29End: 2010-07-01Updated: 2018-08-29